New study for flu treatments19th January 2011
GlaxoSmithKline has started a study testing intravenous zanamivir against Roche's best-selling pill Tamiflu as a treatment for patients hospitalised with influenza.
Intravenous zanamivir is not currently approved for sale in any country, but the British drug maker aims to enrol 462 patients in 20 countries and for a Phase III trial, which will measure the time to clinical response in patients with confirmed flu and take around three years to complete. GSK had previously said it planned to develop an intravenous form of zanamivir to help the sickest patients.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: New study for flu treatments
Author: Mark Nicholls
Article Id: 17275
Date Added: 19th Jan 2011